UCB at FoG London 2027
Jan 27–28, 2027 London, UK ~8.3k attendees Website
UCB takes part in 2 sessions at FoG London 2027 in London. Its sessions cover AI and data in drug development. Concrete topics include synthetic data as a source of evidence in clinical development and whether AI is delivering real breakthroughs or just faster trial and error.
| Organization | FoG London 2027 Attendance |
|---|---|
UCB Brussels, Belgium | |
Belgian biopharmaceutical company developing medicines for neurology and immunology conditions. | Panel Thu Jan 28 11:30–12:00 Are We Seeing Real Breakthroughs from AI, or Just Faster Trial and Error? Whether AI-discovered drugs now reaching mid-stage trials are truly better molecules, and how success for AI in drug discovery should be measured. Talk Thu Jan 28 16:10–16:40 Synthetic Data in Clinical Development: Enabling the Next Generation of Scientific Evidence How industry and regulators are setting rules for using synthetic, computer-generated data in drug development, from trial design to hard-to-study patient groups. Also |
Find decision makers at UCB
Tell us what you sell and we’ll find the people at UCB most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by Front Line Genomics or the Festival of Genomics. Submit a correction